Published in Epilepsia on July 01, 1998
The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol (2013) 1.62
Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ (2002) 1.41
Clinical- and cost-effectiveness of a nurse led self-management intervention to reduce emergency visits by people with epilepsy. PLoS One (2014) 0.88
Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples. PLoS One (2016) 0.81
Epilepsy in India II: Impact, burden, and need for a multisectoral public health response. Ann Indian Acad Neurol (2015) 0.78
Knowledge translation of an online tool to determine candidacy for epilepsy surgery evaluation. Neurol Clin Pract (2016) 0.75
The outcome of initiation of antiepileptic drug monotherapy in primary care: a UK database survey. Br J Gen Pract (2004) 0.75
The DNA sequence of human chromosome 22. Nature (1999) 30.88
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J Exp Med (1994) 5.60
One drug for epilepsy. Br Med J (1978) 4.87
One drug (phenytoin) in the treatment of epilepsy. Lancet (1976) 4.32
Isolation, experimental transmission, and characterization of causative agent of Potomac horse fever. Science (1985) 4.12
Effect of audit and feedback, and reminder messages on primary-care radiology referrals: a randomised trial. Lancet (2001) 3.44
The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2004) 3.41
Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess (2007) 3.40
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet (2005) 3.38
Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med (1990) 3.01
Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol (1993) 3.01
Quality of life of people with epilepsy: a European study. Epilepsia (1997) 2.72
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med (1992) 2.70
The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol (2007) 2.59
Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2001) 2.40
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatry (1976) 2.18
Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology (2004) 2.14
Primary hyperparathyroidism: an analysis of failure of parathyroidectomy. World J Surg (2014) 2.09
Ligneous conjunctivitis involving the cervix. Case report. Br J Obstet Gynaecol (1989) 2.06
Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol (1997) 2.03
Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet (1997) 2.02
Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. Neurology (2007) 1.94
Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism. J Immunol (1993) 1.92
Mushroom body ablation impairs short-term memory and long-term memory of courtship conditioning in Drosophila melanogaster. Neuron (1999) 1.91
Large pragmatic randomised studies of new antiepileptic drugs are needed. BMJ (1997) 1.83
Diabetes risk factors in low-income Mexican-American children. Diabetes Care (1999) 1.82
Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. J Neurol Neurosurg Psychiatry (1977) 1.79
Cortical reflex myoclonus. Neurology (1979) 1.68
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess (2010) 1.67
An epilepsy needs document. Seizure (1993) 1.64
Comparative sequence analysis of the human and pufferfish Huntington's disease genes. Nat Genet (1995) 1.55
Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. Br J Ophthalmol (2007) 1.54
A general practice records audit of the process of care for people with epilepsy. Br J Gen Pract (1996) 1.53
High fertilization rate with intracytoplasmic sperm injection in mosaic Klinefelter's syndrome. Fertil Steril (1995) 1.48
Staging of prostate cancer using 3-dimensional transrectal ultrasound images: a pilot study. J Urol (1999) 1.43
Placebo-controlled studies in neurology: where do they stop? Neurology (1999) 1.40
Admission as a dental student to the former UMDS and its relationship to socio-demographic characteristics. Br Dent J (2003) 1.40
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells (1998) 1.40
Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol (1992) 1.39
Managing the teenager with epilepsy: paediatric to adult care. Seizure (1997) 1.37
Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol (2003) 1.33
The stigma of epilepsy: a European perspective. Epilepsia (2000) 1.32
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS. Neurology (2011) 1.31
A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem (1991) 1.30
Distance stereoacuity in intermittent exotropia. Br J Ophthalmol (2006) 1.30
Measurement of the QT interval. Eur Heart J (1985) 1.25
Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry (1995) 1.24
A cost-utility analysis of interferon beta for multiple sclerosis. Health Technol Assess (1998) 1.24
Primary structure of the succinyl-CoA synthetase of Escherichia coli. Biochemistry (1985) 1.23
Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol (1999) 1.22
Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. J Neurol Neurosurg Psychiatry (1984) 1.22
Pheochromocytoma without hypertension presenting as cardiomyopathy. Am Heart J (1972) 1.21
Perceptions of healthy eating and physical activity in an ethnically diverse sample of young children and their parents: the DEAL prevention of obesity study. J Hum Nutr Diet (2012) 1.17
Lhermitte's "sign" due to thoracic cord compression. J Neurol Neurosurg Psychiatry (1986) 1.16
Workforce planning in dentistry: the impact of shorter and more varied career patterns. Community Dent Health (2001) 1.16
Measuring the impact of epilepsy: the development of a novel scale. Epilepsy Res (1993) 1.14
Rate responsive pacing using a minute ventilation sensor. Pacing Clin Electrophysiol (1988) 1.14
Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet (1995) 1.13
An association between ANCA positive renal disease and malignancy. Clin Nephrol (1993) 1.12
Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia (1993) 1.11
Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut (2005) 1.11
Risk of accidents in drivers with epilepsy. J Neurol Neurosurg Psychiatry (1996) 1.10
Altered 5-HT metabolism with clonazepam, diazepam and diphenylhydantoin. J Pharm Pharmacol (1975) 1.10
Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. J Neurol Neurosurg Psychiatry (2000) 1.10
A crossover, add-on trial of talampanel in patients with refractory partial seizures. Neurology (2002) 1.10
Improving publicly funded substance abuse treatment: the value of case management. Am J Public Health (1997) 1.10
Megaloblastic anemia of infancy secondary to maternal pernicious anemia. N Engl J Med (1966) 1.09
The effectiveness of prophylactic anticonvulsants following neurosurgery. Acta Neurochir (Wien) (1983) 1.09
Phenytoin monotherapy for epilepsy: a long-term prospective study, assisted by serum level monitoring, in previously untreated patients. Epilepsia (1981) 1.08
Geometry of site alignment during int family recombination: antiparallel synapsis by the Flp recombinase. J Mol Biol (2000) 1.08
A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess (2005) 1.08
Manipulation of brain serotonin in the treatment of myoclonus. Lancet (1975) 1.07
Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health Technol Assess (2012) 1.07
Life history determines biogeographical patterns of soil bacterial communities over multiple spatial scales. Mol Ecol (2010) 1.07
Screening for carcinoma of the prostate. BMJ (1990) 1.07
Testicular aspiration of sperm for intracytoplasmic sperm injection: a novel treatment for ejaculatory failure on the day of oocyte retrieval. Fertil Steril (1996) 1.05
Cloning and expression of the succinyl-CoA synthetase genes of Escherichia coli K12. J Gen Microbiol (1986) 1.05
Carbamazepine is not a substrate for P-glycoprotein. Br J Clin Pharmacol (2001) 1.05
Gabapentin as an antiepileptic drug in man. J Neurol Neurosurg Psychiatry (1987) 1.04
Ballistic movement overflow myoclonus a form of essential myoclonus. Brain (1977) 1.04
The quality of life of older people with epilepsy: findings from a UK community study. Seizure (2001) 1.04
Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls. Psychol Med (1994) 1.04
Meanings of epilepsy in its sociocultural context and implications for stigma: findings from ethnographic studies in local communities in China and Vietnam. Epilepsy Behav (2007) 1.03
TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology (2001) 1.02
Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav (1996) 1.02
Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder. Adv Neurol (1986) 1.02
Biological and biochemical characteristics of murine megakaryoblastic cell line L8057. Exp Hematol (1993) 1.01
The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess (2009) 1.01
Epilepsy after first seizures: risks and implications. J Neurol Neurosurg Psychiatry (1991) 1.00
Severe alkalosis in critically ill surgical patients. Arch Surg (1972) 1.00
Mental health in the community. Med Educ (1992) 0.99